Your browser doesn't support javascript.
loading
Progress towards the UNAIDS 95-95-95 targets in the Fifth Botswana AIDS Impact Survey (BAIS V 2021): a nationally representative survey.
Mine, Madisa; Stafford, Kristen A; Laws, Rebecca L; Marima, Reson; Lekone, Phenyo; Ramaabya, Dinah; Makhaola, Kgomotso; Patel, Hetal K; Mapondera, Prichard; Wray-Gordon, Floris; Agbakwuru, Chinedu; Okui, Lillian; Matroos, Susan; Onyadile, Eden; Ngidi, Julia; Abimiku, Alash'le; Bagapi, Khuteletso; Nkomo, Bornapate; Bodika, Stephane M; Kim, Kaylee J; Moloney, Mirna; Mitchell, Andrew; Ehoche, Akipu; Ussery, Faith L; Hong, Steven Y; Keipeile, Stella; Matlhaga, Matshelo; Mathumo, Rapetse; Selato, Robert; Charurat, Manhattan E; Voetsch, Andrew C.
Affiliation
  • Mine M; Ministry of Health, Gaborone, Botswana.
  • Stafford KA; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Laws RL; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Marima R; Botswana University of Maryland School of Medicine Health Initiative (Bummhi), Gaborone, Botswana.
  • Lekone P; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Gaborone, Botswana.
  • Ramaabya D; Ministry of Health, Gaborone, Botswana.
  • Makhaola K; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Gaborone, Botswana.
  • Patel HK; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Mapondera P; Botswana University of Maryland School of Medicine Health Initiative (Bummhi), Gaborone, Botswana.
  • Wray-Gordon F; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Agbakwuru C; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Okui L; Botswana University of Maryland School of Medicine Health Initiative (Bummhi), Gaborone, Botswana.
  • Matroos S; Statistics Botswana, Gaborone, Botswana.
  • Onyadile E; Statistics Botswana, Gaborone, Botswana.
  • Ngidi J; Ministry of Health, Gaborone, Botswana.
  • Abimiku A; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Bagapi K; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Gaborone, Botswana.
  • Nkomo B; Ministry of Health, Gaborone, Botswana.
  • Bodika SM; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Kim KJ; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Gaborone, Botswana.
  • Moloney M; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Mitchell A; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Ehoche A; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Ussery FL; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Hong SY; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Gaborone, Botswana.
  • Keipeile S; National AIDS and Health Promotion Agency, Gaborone, Botswana.
  • Matlhaga M; National AIDS and Health Promotion Agency, Gaborone, Botswana.
  • Mathumo R; National AIDS and Health Promotion Agency, Gaborone, Botswana.
  • Selato R; National AIDS and Health Promotion Agency, Gaborone, Botswana.
  • Charurat ME; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Voetsch AC; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: avoetsch@cdc.gov.
Lancet HIV ; 11(4): e245-e254, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38467135
ABSTRACT

BACKGROUND:

In 2014, UNAIDS set a goal to end the AIDS epidemic by achieving targets for the percentage of people living with HIV who were aware of their status, on antiretroviral therapy (ART), and virally suppressed. In 2020, these targets were revised to 95% for each measure (known as 95-95-95), to be reached among people living with HIV by 2025. We used data from the Fifth Botswana AIDS Impact Survey (BAIS V) to measure progress towards these testing and treatment targets in Botswana.

METHODS:

BAIS V used a two-stage cluster design to obtain a nationally representative sample of people aged 15-64 years in Botswana. During March-August, 2021, 14 763 consenting participants were interviewed and tested for HIV in their households by survey teams. HIV-positive specimens were tested for viral load, presence of antiretroviral drugs, and recency of infection using the HIV-1 limiting antigen avidity enzyme immunoassay. Estimates of HIV-positive status and use of ART were based on self-report and the analysis of blood specimens for antiretroviral drugs. Viral load suppression was defined as an HIV RNA concentration of less than 1000 copies per mL. HIV incidence was calculated using the recent infection testing algorithm. Data were weighted to account for the complex survey design.

FINDINGS:

The national HIV prevalence in Botswana among people aged 15-64 years was 20·8% and the annual incidence of HIV infection was 0·2%. 95·1% (men 93·0%, women 96·4%) of people living with HIV aged 15-64 years were aware of their status, 98·0% (men 97·2%, women 98·4%) of those aware were on ART, and 97·9% (men 96·6%, women 98·6%) of those on ART had viral load suppression. Among young people (aged 15-24 years) living with HIV, 84·5% were aware of their status, 98·5% of those aware were on ART, and 91·6% of those on ART had viral load suppression. The prevalance of viral load suppression among all people living with HIV was 91·8%, and varied by district-ranging from 85·3% in Gaborone to 100·0% in Selibe Phikwe.

INTERPRETATION:

BAIS V is the first population-based survey worldwide to report the achievement of the UNAIDS 95-95-95 goals, both overall and among women. Strategies to reach undiagnosed men and young people, including young women, are needed.

FUNDING:

US President's Emergency Plan for AIDS Relief.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Acquired Immunodeficiency Syndrome Limits: Adolescent / Female / Humans / Male Country/Region as subject: Africa Language: En Journal: Lancet HIV Year: 2024 Type: Article Affiliation country: Botswana

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Acquired Immunodeficiency Syndrome Limits: Adolescent / Female / Humans / Male Country/Region as subject: Africa Language: En Journal: Lancet HIV Year: 2024 Type: Article Affiliation country: Botswana